PJT Partners Inc. Q4 Income Climbs

PJT Partners reported Q4 revenue of $535.16 million, up 12.1% year-over-year from $477.28 million, with GAAP net income of $53.36 million ($1.97/share) versus $51.30 million ($1.83) a year ago. On an adjusted basis the firm posted $111.83 million of earnings, or $2.55 per share, highlighting materially higher adjusted profitability; the top-line growth and stronger adjusted EPS suggest a solid quarter for the advisory firm, though the sizeable gap between GAAP and adjusted results merits scrutiny.

Analysis

Market structure: PJT’s +12.1% revenue growth and $2.55 adjusted EPS signal boutiques are capturing fee pools despite a higher-rate environment; direct beneficiaries include PJT (PJT), Evercore (EVR), and Lazard (LAZ) while pure trading/underwriting franchises at bulge brackets may underperform if fee pools shift. This suggests M&A/restructuring supply (deal advisors) is tight relative to advisor capacity — pricing power for top boutiques can rise 5–15% on key mandates over 6–12 months. Cross-asset: stronger advisory activity is mildly positive for credit spreads and equity risk appetite; expect modest compression in CDS/bond spreads for rated corporates and lower implied volatility in PJT options as confidence rises.

Risk assessment: Tail risks include a sudden 150–300bp widening in corporate credit spreads that could wipe 20–40% of near-term advisory pipeline, or a loss of 1–2 senior rainmakers that could reduce annual revenue by 10–25%. Immediate (days) sensitivity is earnings-guidance and deal announcements; short-term (weeks–months) hinges on announced mandates closing; long-term (quarters–years) depends on sustained market-share versus bulge-brackets. Hidden dependency: revenue concentration in a handful of mega-deals — a single cancelled $1bn+ mandate materially moves quarterly EPS.

Trade implications: Direct play — establish a 2–3% long position in PJT (PJT) within 5 trading days, target a 20–30% upside over 3–9 months; hedge with a 1–1.2% short position in Morgan Stanley (MS) to neutralize broad market beta. Options: buy a 3-month call spread on PJT (ATM to +10%) sized to 0.5–1% of portfolio to cap cost while capturing multiple expansion; take profits if PJT rises 25% or cut losses at -15%. Rotate: overweight boutique advisory (PJT, EVR, LAZ) by +300–500bp and underweight trading/market-making exposure (GS, MS) by similar amount.

Contrarian angles: Consensus may underweight durability of advisory fees — boutiques often see repeat mandates and sticky retainer work that supports margins despite rate volatility; if credit conditions normalize, upside is underappreciated. Conversely, the market may be underpricing concentration risk: if one or two megadeals fail, downside could be sharper than peers — size positions accordingly and prefer staggered option entries to manage idiosyncratic risk.

Key Decisions for Investors

• Establish a 2–3% long position in PJT (PJT) within the next 5 trading days; target 20–30% upside over 3–9 months and set a stop-loss at -15% absolute or if next-quarter adjusted EPS guidance falls >10% vs consensus.
• Implement a pair trade: long PJT 2% notional and short Morgan Stanley (MS) 1.2% notional to hedge market beta; rebalance after 3 months or if the spread between the two returns to the 12-month mean.
• Buy a 3-month PJT call spread (ATM to +10%) sized to 0.5–1% of portfolio as a convex, limited-cost way to capture multiple expansion; exit if implied volatility rises >40% or PJT gains 25%.
• Overweight boutique advisory names (add EVR and LAZ to reach +300–500bp overweight vs benchmark) and reduce exposure to trading/underwriting-heavy banks (reduce GS/MS weight by similar amount) within 30 days.
• Monitor two triggers for position review: (1) corporate credit spread widening >150bps (staggered review within 7 days), and (2) loss of >1 named senior banker or failure/cancellation of any >$100M fee mandate (exit or reduce exposure within 3 trading days).